These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
403 related articles for article (PubMed ID: 39335671)
1. Revolutionizing Cancer Treatment: Recent Advances in Immunotherapy. Ghemrawi R; Abuamer L; Kremesh S; Hussien G; Ahmed R; Mousa W; Khoder G; Khair M Biomedicines; 2024 Sep; 12(9):. PubMed ID: 39335671 [TBL] [Abstract][Full Text] [Related]
2. Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015. Ascierto PA; Agarwala S; Botti G; Cesano A; Ciliberto G; Davies MA; Demaria S; Dummer R; Eggermont AM; Ferrone S; Fu YX; Gajewski TF; Garbe C; Huber V; Khleif S; Krauthammer M; Lo RS; Masucci G; Palmieri G; Postow M; Puzanov I; Silk A; Spranger S; Stroncek DF; Tarhini A; Taube JM; Testori A; Wang E; Wargo JA; Yee C; Zarour H; Zitvogel L; Fox BA; Mozzillo N; Marincola FM; Thurin M J Transl Med; 2016 Nov; 14(1):313. PubMed ID: 27846884 [TBL] [Abstract][Full Text] [Related]
3. Advances in Melanoma: From Genetic Insights to Therapeutic Innovations. Valdez-Salazar F; Jiménez-Del Rio LA; Padilla-Gutiérrez JR; Valle Y; Muñoz-Valle JF; Valdés-Alvarado E Biomedicines; 2024 Aug; 12(8):. PubMed ID: 39200315 [TBL] [Abstract][Full Text] [Related]
4. Glioblastoma Immunotherapy: A Systematic Review of the Present Strategies and Prospects for Advancements. Agosti E; Zeppieri M; De Maria L; Tedeschi C; Fontanella MM; Panciani PP; Ius T Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894718 [TBL] [Abstract][Full Text] [Related]
5. Unleashing the Therapeutic Potential of CAR-T Cell Therapy Using Gene-Editing Technologies. Jung IY; Lee J Mol Cells; 2018 Aug; 41(8):717-723. PubMed ID: 30110720 [TBL] [Abstract][Full Text] [Related]
6. Personalized Immuno-Oncology. Jain KK Med Princ Pract; 2021; 30(1):1-16. PubMed ID: 32841942 [TBL] [Abstract][Full Text] [Related]
7. Revolutionizing Cancer Treatment: Unleashing the Power of Viral Vaccines, Monoclonal Antibodies, and Proteolysis-Targeting Chimeras in the New Era of Immunotherapy. Mohite P; Yadav V; Pandhare R; Maitra S; Saleh FM; Saleem RM; Al-Malky HS; Kumarasamy V; Subramaniyan V; Abdel-Daim MM; Uti DE ACS Omega; 2024 Feb; 9(7):7277-7295. PubMed ID: 38405458 [TBL] [Abstract][Full Text] [Related]
8. Advancements in Immunotherapy for Breast Cancer: Mechanisms, Efficacy, and Future Directions. Rai A; Deshpande SG; Vaidya A; Shinde RK Cureus; 2024 Aug; 16(8):e68351. PubMed ID: 39355073 [TBL] [Abstract][Full Text] [Related]
9. Revolutionizing cancer immunotherapy in solid tumor: CAR engineering and single-cell sequencing insights. Pu Z; Wang TB; Mou L Front Immunol; 2023; 14():1310285. PubMed ID: 38090577 [TBL] [Abstract][Full Text] [Related]
10. Bispecific PSMA antibodies and CAR-T in metastatic castration-resistant prostate cancer. Zarrabi KK; Narayan V; Mille PJ; Zibelman MR; Miron B; Bashir B; Kelly WK Ther Adv Urol; 2023; 15():17562872231182219. PubMed ID: 37359737 [TBL] [Abstract][Full Text] [Related]
11. The Interplay between T Cells and Cancer: The Basis of Immunotherapy. Chen C; Liu X; Chang CY; Wang HY; Wang RF Genes (Basel); 2023 Apr; 14(5):. PubMed ID: 37239368 [TBL] [Abstract][Full Text] [Related]
12. Advances in nano-immunotherapy for hematological malignancies. Xu J; Liu W; Fan F; Zhang B; Sun C; Hu Y Exp Hematol Oncol; 2024 May; 13(1):57. PubMed ID: 38796455 [TBL] [Abstract][Full Text] [Related]
13. Multiplexed engineering and precision gene editing in cellular immunotherapy. Biederstädt A; Manzar GS; Daher M Front Immunol; 2022; 13():1063303. PubMed ID: 36483551 [TBL] [Abstract][Full Text] [Related]
14. Role of Immunotherapy in Targeting the Bone Marrow Microenvironment in Multiple Myeloma: An Evolving Therapeutic Strategy. Chung C Pharmacotherapy; 2017 Jan; 37(1):129-143. PubMed ID: 27870103 [TBL] [Abstract][Full Text] [Related]
15. Immunotherapeutic advances in glioma management: The rise of vaccine-based approaches. Andrew Awuah W; Shah MH; Tan JK; Ranganathan S; Sanker V; Darko K; Tenkorang PO; Adageba BB; Ahluwalia A; Shet V; Aderinto N; Kundu M; Abdul-Rahman T; Atallah O CNS Neurosci Ther; 2024 Sep; 30(9):e70013. PubMed ID: 39215399 [TBL] [Abstract][Full Text] [Related]
16. CAR T Cell Therapy Progress and Challenges for Solid Tumors. Stern LA; Jonsson VD; Priceman SJ Cancer Treat Res; 2020; 180():297-326. PubMed ID: 32215875 [TBL] [Abstract][Full Text] [Related]
17. CAR-macrophage: Breaking new ground in cellular immunotherapy. Huang T; Bei C; Hu Z; Li Y Front Cell Dev Biol; 2024; 12():1464218. PubMed ID: 39421021 [TBL] [Abstract][Full Text] [Related]
18. Revolutionizing cancer treatment: comprehensive insights into immunotherapeutic strategies. Raghani NR; Chorawala MR; Mahadik M; Patel RB; Prajapati BG; Parekh PS Med Oncol; 2024 Jan; 41(2):51. PubMed ID: 38195781 [TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cell suppresses the efficacy of CAR-T toward killing lymphoma cells by modulating the microenvironment through stanniocalcin-1. Zhang R; Liu Q; Zhou S; He H; Zhao M; Ma W Elife; 2023 Feb; 12():. PubMed ID: 36779699 [TBL] [Abstract][Full Text] [Related]
20. Recent advances in immunotherapy in cancer treatment. Patel AA Cell Mol Biol (Noisy-le-grand); 2024 May; 70(5):89-99. PubMed ID: 38814230 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]